• 115298+ Medical Conferences
  • 238 Specialties
  • 25021 Organizers
  • 138411 Speakers
  • 153 Countries
  • 4186 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Mark Bodmer
Mark Bodmer

Mark Bodmer

Chief Scientific Officer, President | Cambridge, Massachusetts    United States of America
Research And Clinical Research
Research And Clinical Research, Immunology,...More
Spoken at 1 event

Biography :

Dr. Mark Bodmer, Ph.D. has been Chief Scientific Officer and President of R&D at Evelo Biosciences, Inc. since April, 2016. Dr. Bodmer served as Head of New Medicines Therapeutics at UCB, leading UCB's research in immunology, neurology and bone disease. Prior to joining UCB, he served as Senior Vice President of Immunoinflammation, at GlaxoSmithKline, where he was also previously Head of Metabolic and Cardiovascular Disease Drug Discovery. From 2000-2007 Dr. Bodmer served as the Chief Executive Officer of Biotica Technology and Lorantis.

Dr. Bodmer served as the Head of Research & Development of Incyte Pharmaceuticals and President of its European subsidiary until November 30, 1999. He served as the Founding Chief Executive Officer of Hexagen since 1996. He served as Director of Biology of Celltech Therapeutics since 1994. Dr. Bodmer joined Celltech group plc, where he held a number of research and development roles. He received a Ph.D. in Genetics from Cambridge University in 1982.

** ************
For speaker's contact information - Contact us


Research and Clinical Research

Interested Topics

Research and Clinical Research, Immunology, Neurology, Life Science, Pharmaceuticals, Drug Development, Drug Discovery, Molecular Biology, Technology Transfer, Biochemistry

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message